Article
Heterogeneity at the invasion front of triple negative breast cancer cells
1 Apr 2020
Abstract excerpt
Identifying better predictive and prognostic biomarkers for the diagnosis and treatment of triple negative breast cancer (TNBC) is complicated by tumor heterogeneity ranging from responses to therapy, mutational burden, and clonal evolution. To overcome the gap in our understanding of tumor heterogeneity, we hypothesized that isolating and studying the gene expression profile of invasive tumor cell subpopulations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
